Presented at: New Orleans Summer Cancer Meeting 20th Anniversary Conference

Chairman: Edgardo S. Santos Castillero, MD, FACP, FASCO

Prostate Cancer: Early and Locally Advanced Disease

Ulka Vaishampayan, MD | University of Michigan

Dr. Ulka Vaishampayan discussed early and locally advanced prostate cancer, noting 192,000 new U.S.cases yearly. Key biomarkers include PSA, imaging, and genomics. High-risk cases may need surgery, radiation, or hormone therapy. Tools like Decipher and Artera AI aid decisions. Multidisciplinary care is key.

Presented at: Specialty Pharmaceutical Summit 2025 SPS Puerto Rico

Summit Directors:

Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC, FACHE | Baptist Health South Florida

Bhavesh Shah, RPh, BCOP | Boston Medical Center

Specialty Pharmaceuticals | The Payer Perspective

Moderator: Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC,FACHE | Baptist Health South Florida

Panel: Iris L. Morant Rodriguez, BS Pharm, RPh | MSO Puerto Rico; Gladiany Ramos-Marrero, PharmD, RPh, CSP | MCS Puerto Rico; Nury Toledo Nunez, PharmD | SSS HealthPuerto Rico

The panel explored Puerto Rico’s healthcare landscape, noting heavy reliance on Triple S, MMM, and MCs, with a$5.8 billion 2025 budget dominated by Medicare and oncology costs. Key challenges include underfunding, specialty drug management, and the need for stakeholder collaboration, biosimilars, and AI integration to improve outcomes.

Presented at: Specialty Pharmaceutical Summit 2025 SPS Puerto Rico

Summit Directors:

Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC, FACHE | Baptist Health South Florida

Bhavesh Shah, RPh, BCOP | Boston Medical Center

Specialty Pharmaceuticals in Puerto Rico: The Pharmaceutical Industry Perspective

Co-Moderators: Jorge J. Garcia, PharmD, MS, MHA, MBA,FACCC, FACHE | Baptist Health South Florida; Bhavesh Shah, RPh, BCOP | Boston Medical Center

Panel: Nelson Hernandez Gonzalez, MBA | Sanofi; Karyna Holmberg | AstraZeneca; Janice Diaz, PhD | Bristol MyersSquibb Puerto Rico

The discussion addressed life science industry challenges in Puerto Rico, emphasizing culturally relevant content, AI-driven evidence management, and local specialty pharmacy support. Solutions such as bridge doses, value-based contracts, and enhanced collaboration were proposed to improve patient access and outcomes.